In introduction to SILS 2015 panel of international specialists on “Aging of the Population: Opportunity or Threat?”
By : Carine Boonen, Flanders' Care (Belgium)
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
NUS-ISS Seminar: Data-Driven Opportunities for Improved Population Health Management, by Ms Catherine Khaw, Chief, Intelligent Systems Practice, NUS-ISS
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Clinical Trial Data Transparency: Explaining Governance for Public Data SharingHealth Data Consortium
Watch the webinar here: http://www.screencast.com/t/0lATKYlJ8
Dr. Chris Boone, then-VP in Avalere’s Evidence Translation and Implementation Practice, discussed clinical trial data transparency and considerations for governance and open data sharing. Clinical trials are extremely valuable as the primary data source for seeking regulatory approval of products. Historically, regulatory agencie have been the sole recipients of clinical trial data, butthere has been a recent push from various stakeholder groups to open access to clinical trial data to non-regulatory researchers as an act of ethical responsibility to patients, a contribution to public health, and a demonstrated commitment to advancing the science. Some of the barriers include developing a sound approach for de-identifying patient data, adopting universal clinical trial data format, and managing the proactive and non-selective access and security of clinical data once collected. Dr. Boone discusses rationales and benefits/risks of clinical trial transparency, responsible use of publicly sharing this data, barriers and legal implications, and reasonable data sharing models.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
Reinventing Life Sciences: How emerging ecosystems fuel innovationIBM in Healthcare
Persistent disruptive forces in life sciences now threaten traditional business models over the medium to long term. While high rates of return and strong performance may have masked these forces in the past, today they must be recognized and addressed. Organizations need new ways to continue to thrive despite such hurdles.
This latest research study by IBM Instritute of Business Value in collaboration with the University of California, San Diego and Oxford Economics, led to a target innovation model that can guide organizations to discover operational efficiencies, nurture new growth and get positioned more strategically in the new life sciences and healthcare ecosystem.
This Slideshare discusses the current state, technical and workflow challenges, and the future state of Patient Generated Health Data. Learn more: https://accntu.re/2KeGkZ6
In July 2018, NITI Aayog published a Strategy and Approach document on the National Health Stack. The document underscored the need for Universal Health Coverage (UHC) and laid down the technology framework for implementing the Ayushman Bharat programme which is meant to provide UHC to the bottom 500 million of the country. While the Health Stack provides a technological backbone for delivering affordable healthcare to all Indians, we, at iSPIRT, believe that it has the potential to go beyond that and to completely transform the healthcare ecosystem in the country. We are indeed headed for a health leapfrog in India! Over the last few months, we have worked extensively to understand the current challenges in the industry as well as the role and design of individual components of the Health Stack. In this post, we elaborate on the leapfrog that will be enabled by blending this technology with care delivery.
NUS-ISS Seminar: Data-Driven Opportunities for Improved Population Health Management, by Ms Catherine Khaw, Chief, Intelligent Systems Practice, NUS-ISS
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Clinical Trial Data Transparency: Explaining Governance for Public Data SharingHealth Data Consortium
Watch the webinar here: http://www.screencast.com/t/0lATKYlJ8
Dr. Chris Boone, then-VP in Avalere’s Evidence Translation and Implementation Practice, discussed clinical trial data transparency and considerations for governance and open data sharing. Clinical trials are extremely valuable as the primary data source for seeking regulatory approval of products. Historically, regulatory agencie have been the sole recipients of clinical trial data, butthere has been a recent push from various stakeholder groups to open access to clinical trial data to non-regulatory researchers as an act of ethical responsibility to patients, a contribution to public health, and a demonstrated commitment to advancing the science. Some of the barriers include developing a sound approach for de-identifying patient data, adopting universal clinical trial data format, and managing the proactive and non-selective access and security of clinical data once collected. Dr. Boone discusses rationales and benefits/risks of clinical trial transparency, responsible use of publicly sharing this data, barriers and legal implications, and reasonable data sharing models.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
Reinventing Life Sciences: How emerging ecosystems fuel innovationIBM in Healthcare
Persistent disruptive forces in life sciences now threaten traditional business models over the medium to long term. While high rates of return and strong performance may have masked these forces in the past, today they must be recognized and addressed. Organizations need new ways to continue to thrive despite such hurdles.
This latest research study by IBM Instritute of Business Value in collaboration with the University of California, San Diego and Oxford Economics, led to a target innovation model that can guide organizations to discover operational efficiencies, nurture new growth and get positioned more strategically in the new life sciences and healthcare ecosystem.
This Slideshare discusses the current state, technical and workflow challenges, and the future state of Patient Generated Health Data. Learn more: https://accntu.re/2KeGkZ6
In July 2018, NITI Aayog published a Strategy and Approach document on the National Health Stack. The document underscored the need for Universal Health Coverage (UHC) and laid down the technology framework for implementing the Ayushman Bharat programme which is meant to provide UHC to the bottom 500 million of the country. While the Health Stack provides a technological backbone for delivering affordable healthcare to all Indians, we, at iSPIRT, believe that it has the potential to go beyond that and to completely transform the healthcare ecosystem in the country. We are indeed headed for a health leapfrog in India! Over the last few months, we have worked extensively to understand the current challenges in the industry as well as the role and design of individual components of the Health Stack. In this post, we elaborate on the leapfrog that will be enabled by blending this technology with care delivery.
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
SILS 2015 - Connecting Precision Medicine to Precision Wellness Sherbrooke Innopole
By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Capital intellectuel – Votre entreprise est assise sur une mine d’or Sherbrooke Innopole
Présentation faite par Luc Bérubé, agent de brevets certifié et fondateur de Bérubé Capital Intellectuel, dans le cadre du déjeuner du GATE, le 5 février 2016 à Sherbrooke.
Lisez le blogue résumé -> http://bit.ly/1UcigTo
Présentation faite par Lise Vaillancourt, directrice régionale adjointe, Estrie et Montérégie au ministère du Développement durable, de l’Environnement et de la Lutte contre les changements climatiques (MDDELCC) du Québec, le 18 février 2016 à Sherbrooke dans le cadre d'un déjeuner-conférence organisé par le Créneau ACCORD des bio-industries environnementales (CABIE), en collaboration avec Sherbrooke Innopole.
De Hogeweyk, the Care Concept – Living life as usual with an advanced dementia
By: Yvonne van Amerongen, De Hogeweyk and Oversingel, part of the Vivium Care Group
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
By: Pierre-Carl Michaud, Industrial Alliance Research Chair on the Economics of Demographic Change
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
2014: The Year of the Beacon, and the Future of Location-Based MarketingDavid Berkowitz
It's no longer the year of mobile, or even the year of the selfie. It's the year of the beacon, popularized by Apple's iBeacon but also used by startups like Estimote, NewAer, Nomi, and Shopkick. Location data comes from a wide range of sources now, including ads, apps, retail, social media, cars, connected devices, and wearable tech.
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Belgium
Working across disciplines for our health benefit - From successful strategies for biotech and nanotech to Nanotech for Health in Flanders
Wolfgang Eberle
Funded Program Manager Life Science Technologies Imec
=======================================
http://www.eurobioforum.eu
Presentation "Innovating for Health and Well-being" at WHO International Healthy Cities conference, Athens, Greece, 25/OCT/2014, Arto Holopainen, Development Director, Kuopio Innovation Ltd.
The Medical Learning Hub (MLH) is an e-learning platform that enables healthcare professionals (HCPs) to train and interact with leading medical experts globally and our ambition is to transform medical training by democratizing and making available the latest innovations and opportunities to all HCPs in a highly efficient way.
The Digital Health Society (by Julien Venne) @ICT2018 Vienna 6th Dec 2018Julien VENNE
The Digital Health Society is a movement involving all stakeholders innovating for a better health and wellbeing of citizens. Presentation done by Julien Venne at the ICT2018 organised by the European Commission in Vienna in December 2018. Learn about and join the movement on www.thedigitalhealthsociety.com
CORD Rare Drug Conference: June 8-9, 2022
Global, International, and National Rare Disease Networks
WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Professor George Crooks - ECO 19: Care closer to homeInnovation Agency
Presentation by Professor George Crooks, Chief Executive Officer, The Digital Health and Care Innovation Centre at ECO 19: Care closer to home on Tuesday 9 July at Deepdale Stadium.
Finn Medi Presentation study visit (Life Sciences Sector)TR3S PROJECT
Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.
COVID-19 | Chaîne d'approvisionnement : enjeux et tendancesSherbrooke Innopole
Cette présentation faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 22 avril 2021 traite de :
− Importance de la fonction approvisionnement
− Impacts de la pandémie sur les chaines d’approvisionnement et la logistique de transport
− Tendances à venir dans les chaines d’approvisionnement
− Piste de solutions
Avec :
− Réal Julien, président de J2 gestion d’approvisionnement inc.
− Jimmy Cardin, directeur du développement commercial Aérospatial chez Bolloré Transport et logistique
− Jean-Louis Moreau, consultant achat / approvisionnement et directeur achats de transition
Dans le cadre de ce point d'information organisé par Sherbrooke Innopole le 7 janvier 2020, il est question de :
─ Mesures de confinement ciblant le secteur manufacturier
─ Couvre-feu et exceptions
─ Responsabilités de l'employeur
Cette présentation, faite par Christophe Roux-Dufort, professeur titulaire au Département de management de la Faculté des sciences de l’administration, Université Laval, dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 29 octobre 2020, traite de :
─ Savoir identifier les enjeux soulevés par la crise actuelle, pour les entreprises
─ Principes de gestion de crise : Comment gérer les nouvelles priorités liées au contexte de pandémie
─ Que peut-on d’ores et déjà apprendre pour se préparer à la suite
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravailSherbrooke Innopole
Cette présentation, faite par Philippe-Antoine Plante, enseignant en informatique au Cégep de Sherbrooke, dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 15 octobre 2020, traite de :
1. Télétravail et cybersécurité
─ Sécuriser les ordinateurs de vos employés en télétravail
─ Créer un accès à distance sécuritaire, un VPN, pourquoi, comment?
─ Autres aspects de sécurité (ex. impression à la maison de documents sensibles)
2. Office 365 et Teams : des outils pour le télétravail
─ Les fonctionnalités pour bien utiliser ces outils
─ Collaboration et gestion des changements
3. Présentation de l'AEC Cybersécurité et sécurité intégrée du Cégep de Sherbrooke
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 18 juin, traite des perspectives économiques dans le contexte de la COVID-19 :
─ L’ampleur de la crise dans une perspective historique
─ Quelle sera l’évolution des principaux indicateurs économiques?
─ Quel sera l’impact économique d’une 2e vague de la pandémie?
─ Quelle tendance observerons-nous sur le dollar US?
─ Quel rôle joueront les PME dans la reprise au Canada?
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 18 juin 2020, traite de : Stratégies et instruments : marché des devises, en contexte de COVID-19.
Par BMO
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 28 mai 2020, traite : La transformation numérique des entreprises, c'est plus qu'une numérisation de la production.
Par Productique Québec
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...Sherbrooke Innopole
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 21 mai 2020, traite de diversification de marché dans le contexte de la COVID-19.
Par Carrefour Québec International (CQI)
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 21 mai 2020, démystifie l'assurance crédit sur les marchés canadiens et internationaux comme avenue pour se prémunir contre les mauvaises créances dans le contexte de la COVID-19.
Par Christine Noordberg, courtière en assurance de dommages des entreprises, spécialisée en assurance crédit, Cabinet Noordberg & associés inc.
Cette présentation, faite dans le cadre d'un webinaire organisé par Sherbrooke Innopole le 14 mai 2020, démystifie le droit de refus au travail de l’employé, qui, notamment :
• Doit travailler à l’étranger;
• Est immunosupprimé;
• A 70 ans et plus;
• A peur;
• Fait de l’anxiété.
Par Marie-Claude Riou, avocate, CRHA, médiatrice accréditée chez Vaillancourt Riou & associés s.e.n.c.r.l.
Sherbrooke Innopole a présenté un bilan positif de la stratégie déployée et des actions posées ces 10 dernières années, soit depuis sa création en 2009, en conférence de presse le 18 septembre 2019.
Communiqué > http://bit.ly/2m0CNTe
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situationSherbrooke Innopole
Présentation faite par le MÉI dans le cadre du déjeuner-conférence organisé par le Réseau de transformation métallique du Québec, le ministère de l’Économie et de l’Innovation du Québec et Sherbrooke Innopole, le 21 novembre 2018 à Sherbrooke.
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesuresSherbrooke Innopole
Présentation faite par Laurin Groupe conseil dans le cadre du déjeuner-conférence organisé par le Réseau de transformation métallique du Québec, le ministère de l’Économie et de l’Innovation du Québec et Sherbrooke Innopole, le 21 novembre 2018 à Sherbrooke.
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...Sherbrooke Innopole
Présentation faite par Olivier Paradis et Russel Tremblay, Institut technologique de maintenance industrielle dans le cadre du déjeuner du GATE sur la maintenance industrielle à l’ère de l’Industrie 4.0 / 1er juin 2018 à Sherbrooke
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American BiltriteSherbrooke Innopole
Présentation faite par martin Houle, American Biltrite dans le cadre du déjeuner du GATE sur la maintenance industrielle à l’ère de l’Industrie 4.0 / 1er juin 2018 à Sherbrooke
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-sSherbrooke Innopole
Présentation faite par Patrick Joncas, Exo-s dans le cadre du déjeuner du GATE sur la maintenance industrielle à l’ère de l’Industrie 4.0 / 1er juin 2018 à Sherbrooke
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.orgSherbrooke Innopole
Présentation faite par Elaine Mosconi et Luis Antonio de Santa-Eulalia, IntelliLab.org, Université de Sherbrooke dans le cadre du déjeuner du GATE sur la robotique collaborative / 13 avril 2018 à Sherbrooke
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
2. Flanders’ Care:
Common policy
initiative
Minister-President of the Government of
Flanders and
Flemish Minister for Foreign Policy
Vice-Minister-President of the Government
of Flanders and
Flemish Minister for Budget and Finance
Flemish Minister for Work, Economy and
Innovation
Flemish Minister for Welfare, Public
Health and Family
4. Mission Statement
To measurably improve
the quality of care and
to stimulate responsible
entrepreneurship through
innovation in healthcare
industry
5. Lifelong Integrated
Care
Prevention Cure Chronic Care
Hyperconnectivity / Wearables / Electronic Health Records / ICT backbone / Cloud
Diagnosis
Hospital
Treatment
Care
EXTRA
MUROS
INTRA MUROS EXTRA
MUROS
HOME OT IC HOSP REHAB HOMEER
11. Covering the Innovation Cycle
Demonstration Projects
RESEARCH &
DEVELOPMENT IMPLEMENTATION INTERNATIONAL
VALORIZATION
DEMONSTRATION
Care Living Labs
Contact Point for
Entrepreneurs
New Industrial Policy
Health Economics
KEA (idea – prototyping - start-up)
Toolboxkit
Evidence Based
Care
Roadmap User Centered Approach
Online Data Bank
13. Digital research and
entrepreneurship hub
DIGITAL
RESEARCH
BUSINESS
INCUBATION
Strategic
research
Applied
research
Spin-offs
Global expansion
for tech businesses
Start-up support
for (student) entrepreneurs
Living lab research
European
research projects
Future Internet acceleration
for SMEs
MARKETS
14. REAL LIFE TEST OF
DEVELOPED
PROTOTYPE
ECONOMICAL
VALORISATIO
Development
FEEDBACK OF END USER
CLINICAL DATA
Demonstration
projects
16. 16
Digital Health Living Lab
Methods
Active user involvement
Understanding the
ecosystem from the
perspective of its key
participants
Goals, potential gains,
and most desirable future
outcomes
Commitment to academic
enrichment
Changing expectations of
customers and
stakeholders influencing
the industry
Access to European
Health Living Lab
community
International scaling
Community
Management
Active user-research
Data-driven market
insights
Cross-boarder
leveraging
Multi-actor approach
Health specific
strategies:
• Recruitment
• Motivation
• Feedback
17. MedTech Flanders
Medical technology as a
catalyst for
innovative healthcare
Cluster of MedTech companies
and
activities
Founded by entrepreneurs
Local and international
interaction and
cooperation
18. New Industrial Policy Health
Economics
Lead customer – generic need
New cooperation models
Care sector
Entrepreneurs
Knowledge centers
Local government
Patient centered
20. KEA – idea start-up
1. Intensive support start-ups in care economy
2. Awareness - Ideation – Health Accelerator Boot
Camp
3. Personalised and tailor made support to
improve the maturity of the entrepreneur
4. Prototyping
21. Toolboxkit Evidence Based Care
1. Online
2. Outcome – framework of study methodology
3. Related to product or service
4. End user
Transparency towards evidence methodologies
22. 22
FOUR CHALLENGES FOR THE FUTURE
integration of digital innovations
in healthcare
citizen health empowerment
adjusted legal and ethical
framework
clinical validation
and regulation
of digital solutions
23. DOKZ
1. Profiles – Flemish & English
2. Matchmaking (business & partnerships)
3. Opportunities for finding EU project partners
4. Disclosing regional potential
Online Data Bank
Accessible for actors in Flanders’ Health
Economics
24. Nano4Health –
Cross Cluster Cooperation Model
Emerging opportunities for jobs & growth
Policy level:: framing
Cluster level::supporting
Stakeholder level:delivering
Tangible shared value
25. Cross Cluster Cooperation Model
1. System innovation
2. Multilayer model (knowledge centers, government/policy
level, cluster organisations, companies, end users (care
organisations/persons)
3. Defining the roll and responsibility of each level
4. Developing efficient and complementary tools for each
level
5. Creating an open international cross cluster model
27. SG Healthcare –
Enterprise Europe Network
1. 35 Member Regions
2. Bringing together providers and recipients of healthcare
technology and knowhow
3. Providing companies with advice and support
4. Helping companies find European partners
5. Raising awareness and informing companies about
relevant EU regulations and directives
6. Matchmaking (business & partnerships)
7. Opportunities for finding EU project partners
8. Disclosing regional potential
1 of 17 dedicated Sector Groups in E.E.N.
28. Contact Flanders’ Care
Enterprise Flanders
Lieve Apers
lieve.apers@agentschapondernemen.be
Flanders Investment & Trade
Jan Bruffaerts
jan.bruffaerts@fitagency.be
Department of Welfare, Public Health &
Family
Fabian Dominguez
fabian.dominguez@wvg.vlaanderen.be
Loes Houthuys
loes.houthuys@wvg.vlaanderen.be
Carine Boonen
carine.boonen@wvg.vlaanderen.be